Page 30 - பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா இல் சாந்தா பார்பரா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alpine Immune Sciences Appoints Natasha Hernday to Board of Directors SEATTLE (Business Wire) Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced that Natasha A. Hernday has joined Alpine’s Board of Directors. Ms. Hernday brings more than 20 years of experience in corporate development and corporate strategy. “I’m delighted to welcome Natasha to Alpine Immune Sciences’ Board at this important moment in our company’s history, as we build on our strategic partnership with AbbVie and leverage Alpine’s financial strength to further advance our development pipeline,” said Mitchell H. Gold, M.D., Executive Chairman and Chief Executive Officer of Alpine. “I look forward to benefiting from Natasha’s extensive experience and acumen as we oversee the next stages of Alpine’s growth to the benefit of Alpiners, shareholders an

United statesPaul sekhriLaurence wattsNatashaa herndayPaul rickeyAlpine immune sciences incSeagen incExchange commissionBiopharma incUniversity of california at santa barbaraCorporate developmentGilmartin groupAmgen incXoma corpSecurities exchangePepperdine university